Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» EU Panel Recommends That Elan Update Tysabri MS Drug Label
EU Panel Recommends That Elan Update Tysabri MS Drug Label
EU Panel Recommends That Elan Update Tysabri MS Drug Label
Submitted by
admin
on April 18, 2011 - 10:59am
Source:
Bloomberg
News Tags:
Europe
Elan
MS
multiple sclerosis
Tysabri
Headline:
EU Panel Recommends That Elan Update Tysabri MS Drug Label
Do Not Allow Advertisers to Use My Personal information
